TY  - GEN
AU  - James,Roshan
AU  - Vishwakarma,Siddharth
AU  - Chivukula,Indira V
AU  - Basavaraj,Chetana
AU  - Melarkode,Ramakrishnan
AU  - Montero,Enrique
AU  - Nair,Pradip
TI  - EGFR targeting monoclonal antibody combines with an mTOR inhibitor and potentiates tumor inhibition by acting on complementary signaling hubs
SN  - 2045-7634
PY  - 2014///0127
KW  - Animals
KW  - Antibiotics, Antineoplastic
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cell Proliferation
KW  - Drug Synergism
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Humans
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Mitogen-Activated Protein Kinases
KW  - Molecular Targeted Therapy
KW  - Neoplasm Transplantation
KW  - Neoplasms
KW  - drug therapy
KW  - STAT3 Transcription Factor
KW  - Signal Transduction
KW  - drug effects
KW  - Sirolimus
KW  - TOR Serine-Threonine Kinases
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cam4.21
ER  -